Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

14.760
+0.0300.20%
Volume:21.11M
Turnover:308.80M
Market Cap:37.11B
PE:3.67
High:14.830
Open:14.730
Low:14.440
Close:14.730
52wk High:34.905
52wk Low:14.440
Shares:2.51B
HK Float Shares:2.51B
Volume Ratio:1.11
T/O Rate:0.84%
Dividend:0.25
Dividend Rate:1.71%
EPS(LYR):4.022
ROE:35.88%
ROA:22.68%
PB:1.15
PE(LYR):3.67
PS:1.77

Loading ...

3SBio Buys Back 1.00 Million Shares for HKD 14.80 Million, Treasury Stock Rises to 23.98 Million

Bulletin Express
·
Oct 12

Is 3SBio (SEHK:1530) Cheap On Its MindRank AI Obesity Drug Deal?

Simply Wall St.
·
Oct 10

3SBIO Repurchases 2.5 Million Shares for HK$37.588 Million on October 9

Stock News
·
Oct 09

3SBIO Spends HK$26.5 Million to Repurchase 1.7 Million Shares on October 8

Stock News
·
Oct 08

Hong Kong Stock Market Movers: Innovative Drug Stocks Deepen Losses in Afternoon Session, Ascletis Pharma-B (01672) Falls Over 10%, Innovent Bio (01801) Drops Nearly 4%

Stock News
·
Oct 08

Will Oral Obesity Drug Rights Change 3SBio (SEHK:1530) Narrative

Simply Wall St.
·
Oct 07

3SBio Inc.: Citigroup Inc. Disposes of Shares, Long Position Falls to 4.89%

HK Disclosure
·
Oct 07

3SBio Cuts Outstanding Shares by 10.20 Million in September amid HK$160.96 Million Buy-back, Confirms Public Float Compliance

Bulletin Express
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Citigroup Inc crosses 5% threshold in 3SBio Inc

HK Disclosure
·
Oct 02

Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%

Stock News
·
Oct 02

Movement Alert|3SBIO Falls 5.61% in Regular Trading, Trading at 15.58 HKD

Market Focus
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 30

3SBio H1 2026: Revenue Rises 3.9% on Pfizer Milestone, Yet Core Drug Pressure Cuts Profit

Bulletin Express
·
Sep 30

3SBIO Shares Rise Over 3% as Subsidiary Mandy Partners with MindRank for Exclusive MDR-001 Collaboration

Stock News
·
Sep 30

Mindrank AI: Collaboration Covers Mainland China, Hong Kong and Macau, with a Total Potential Transaction Value of up to RMB 1.75 Bln (USD 260 Mln)

THOMSON REUTERS
·
Sep 28

Mindrank AI Ltd : Partners with 3SBio to Commercialize Its AI-Designed Oral Glp-1 in China

THOMSON REUTERS
·
Sep 28

Mindrank AI: Will be Eligible for up to RMB 1.6 Bln in Additional Milestone Payments

THOMSON REUTERS
·
Sep 28

3SBIO Spends HK$20.41 Million to Buy Back 1.3 Million Shares on September 28

Stock News
·
Sep 28

3SBio Executes HK$20.41 Million On-Market Buyback, Cuts Free-Float by 0.05%

Bulletin Express
·
Sep 28